Thoratec to acquire HeartWare International for $282 million
Upon completion of the transaction, HeartWare’s operations will be integrated into Thoratec’s cardiovascular division and the combined company will offer a broad portfolio of approved devices and will
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.